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Abstract
Cell‐free systems containing multiple enzymes are becoming an increasingly
interesting tool for one‐pot syntheses of biochemical compounds. To extensively
explore the enormous wealth of enzymes in the biological space, we present methods
for assembling and curing data from databases to apply them for the prediction of
pathway candidates for directed enzymatic synthesis. We use Kyoto Encyclopedia of
Genes and Genomes to establish single organism models and a pan‐organism model
that is combining the available data from all organisms listed there. We introduce a
filtering scheme to remove data that are not suitable, for example, generic
metabolites and general reactions. In addition, a valid stoichiometry of reactions is
required for acceptance. The networks created are analyzed by graph theoretical
methods to identify a set of metabolites that are potentially reachable from a defined
set of starting metabolites. Thus, metabolites not connected to such starting
metabolites cannot be produced unless new starting metabolites or reactions are
introduced. The network models also comprise stoichiometric and thermodynamic
data that allow the definition of constraints to identify potential pathways. The
resulting data can be directly applied using existing or future pathway finding tools.
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1 | INTRODUCTION
The enzymatic potential of the numerous enzymes in nature is a most
promising, extremely versatile, and powerful resource for creating
powerful tools for the production of various interesting products.
Besides the production in host organisms, synthesis using cell‐free
systems gains more and more interest. Particularly multistep
biocatalysis seems only marginally explored today compared to its
expected huge potential (Krauser & Weyler, 2013). Cell‐free systems
for the synthesis range from mixtures of isolated enzymes
over multienzyme systems, for example, multienzyme complexes
(S. Z. Wang et al., 2017) and enzyme cascades, to cell lysates (Endo &
Koizumi, 2001) and permeabilized cells. In special cases, such
systems are even combined with chemical synthesis in one pot
(Groeger & Hummel, 2014).
The design of a multistep synthesis route does not only require
the determination of the reaction sequence leading to the desired
product, but also depends on numerous aspects such as substrate
and cofactor supply or thermodynamics. For living cells, a recent
review article discusses the state‐of‐the‐art computational tools for
design and reconstruction of metabolic pathways (Wang, Dash,
Ng, & Maranas, 2017). To design such a pathway for cell‐free
biosynthesis is by far not developed to such a mature state. In
particular, it seems almost impossible to explore manually all
potentially feasible pathways and to determine which one is the
most suitable for production.
The in silico path‐finding and design methods all require a
metabolic network model containing all required information from
the host organisms of interest, such as enzyme, reaction, and
thermodynamics data.
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There is an ever‐growing plethora of biological databases with
enzyme and reaction data of an ever‐growing number of organisms
that is suited for the reconstruction of genome‐scale metabolic
networks. One of the most popular databases is Kyoto Encyclopedia
of Genes and Genomes (KEGG; Kanehisa & Goto, 2000; Kanehisa,
Furumichi, Tanabe, Sato, & Morishima, 2016, 2018). However,
despite the huge amount of data collected from primary literature
that is carefully curated afterwards, the data is partly incomplete,
and sometimes even inconsistent or erroneous. It is thus a challenge
to handle these data and make them suitable for useful network
reconstructions.
We already presented a computational tool to guide and support
finding the most suitable synthesis path to a product (Blaß, Weyler, &
Heinzle, 2017). We extended this study by developing a method of
building network models from KEGG data, which is suitable for path‐
finding. We selected nine organism networks that are of interest
primarily for their application in cell‐free production. Some were
selected because of peculiarities of the networks. Finally, a so‐called
pan‐organism network was used lumping all metabolic reactions
listed in KEGG in one single network.
2 | MATERIALS & METHODS
In the following, we give a short introduction to our path‐finding
method. We also present how to build network reconstruction
models based on data found in biological databases, particu-
larly KEGG.
2.1 | Path‐finding
We already presented a method for finding candidates for suitable
synthesis pathways in genome‐scale metabolic network reconstruc-
tions starting from arbitrary substrates (Blaß et al., 2017). A
pathway in our definition consists of two parts. First, the so‐called
linear path consists of a sequence of metabolites connected by
reactions. It starts with a reaction that has one of the possible
predefined start metabolites as a substrate and ends with a reaction
that has the target metabolite T as a product. Second, there is the
set of supplying reactions, which provide the substrates required by
the reactions on the pathway that are not contained in the
metabolite pool. All metabolites in this pool are considered freely
available since they will be provided by the specified pathway
reactions (see Section 2.2).
The path‐finding algorithm is based on a mixed‐integer linear
program (MILP) and combines graph‐based path‐finding and reaction
stoichiometry (Pey, Prada, Beasley, & Planes, 2011). The method is
elaborated in detail in Blaß et al. (2017). Figure 1 shows an
exemplary pathway illustrating a possible solution of the MILP. The
pathway shown is a feasible synthesis pathway to the target T
(depicted as red octagon). Metabolites in the figure are depicted as
squares, where large squares represent metabolites in arcs (see
Section 2.2) and small squares represent cofactors and inorganic
metabolites. Reactions are represented by circles. The linear path of
the pathway is marked with a blue background. Metabolites S1 to S4
and M1 (marked in green) are contained in the metabolite pool (see
Section 2.2) and are thus initially available. As M4, which is required
by reaction R3, is not available from the metabolite pool, R4 is
needed as a supplying reaction producing it.
In addition to the 17 constraints of the MILP presented in Blaß
et al. (2017), we added a constraint which prevents the use of a
reaction in the pathway (more precisely, the supplying reactions) that
consumes the target. This constraint is necessary to prevent cycles
formed by a reaction belonging to the linear path that produces the
target and a supplying reaction consuming the target to produce a
precursor, which is consumed by a reaction on the linear path. It thus
prevents pathways for which the target has to be already present in
at least catalytic amounts. An example for such an undesired
pathway is shown in Figure 2. In this example, the target T needs
to be consumed by reaction R6 to form metabolite M4, which is
required by reaction R5 to produce the target T.







F IGURE 1 Exemplary pathway illustrating a feasible pathway to
the target metabolite T (red octagon). Large squares: metabolites
with arcs (see Section 2.2); small squares: cofactors/inorganic
metabolites; green: metabolites from the metabolite pool (see
Section 2.2); circles: reactions; blue background: linear path; R4:








F IGURE 2 Exemplary pathway illustrating a pathway to the
target metabolite T (red octagon) where T needs to be consumed to
produce M4. Large squares: metabolites with arcs; small squares:
cofactors/inorganic metabolites; green: metabolites from the
metabolite pool; circles: reactions; blue background: linear path; R4
is a supplying reaction. This pathway example is not a valid synthesis
pathway candidate for T [Color figure can be viewed at
wileyonlinelibrary.com]
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2.2 | Model building
In the following, we define the different parts of our network
reconstruction and model based on KEGG data.
The reactions and metabolites in the model are given as lists of
KEGG REACTION and COMPOUND ids (Kanehisa et al., 2016).
The reactions and metabolites are connected by arcs, which are
derived from reactions.
The metabolites in the model are categorized into sets that are
treated differently in the path‐finding algorithm. One set consists of
potential start metabolites. These are all metabolites in the model that
can be used as the start of the linear path of a pathway candidate.
Metabolites in this category are automatically determined and have a
molecular mass smaller than 300 and occur in arcs. The so‐called basis
metabolites are expert‐curated metabolites, which are inexpensive,
easily available, and are often hubs in the arc network, such as
D‐glucose (C00031) or pyruvate (C00022). The cofactors (e.g., ATP
[C00002], NADH [C00004] and so forth) and inorganics such as water
(C00001), oxygen (C00007) or CO2 (C00011) are a set of
expert‐curated metabolites that are considered as freely available if
they are required as substrates in reactions, but are not part of the
reaction chain. They are thus excluded from the arcs to prevent
biologically meaningless shortcuts in the pathways. All metabolite sets
are disjoint, except for the basis metabolites that form a subset of the
start metabolites. The metabolite pool is the superset of metabolites that
are considered as freely available. It is made up of start metabolites,
basis metabolites, cofactors, and inorganic metabolites. Further details
on the different categories are given in Blaß et al. (2017).
For each reaction, there is a set of arcs, which are substrate–product
pairs of a reaction. There are different strategies to derive the arcs from
a reaction. The straightforward method is using all possible combinations
(i.e., the cross product) of substrates and products of a reaction. It is
however more useful to use meaningful substrate–product pairs, such as
reactant pairs. A reactant pair is a substrate–product pair with both
parts having atoms or atom groups in common that preserves
the chemical substructures of the reactants through the reaction
(Kotera et al., 2004; Kotera, Okuno, Hattori, Goto, & Kanehisa, 2004).
The reactant pairs are defined in the KEGG RCLASS database, which
classifies reactions based on the chemical structure patterns of their
substrate–product pairs (Muto et al., 2013). Only those reactant pairs
are used for the arcs that do not contain any metabolite from the
cofactor and inorganics list. This means, however, that reactions
involving metabolites from this list are still represented by the remaining
arcs. A more detailed discussion on the arcs can be found in Section 1.4
of Material S2 (Tables B12–B16). The arc graph of the model is a
directed graph G= (V, E), where V is the set of metabolites and E is the
set of arcs between these metabolites.
The model also contains a stoichiometric matrix, where each row
corresponds to a metabolite in the model and each column indicates
a reaction. An entry in the matrix is the stoichiometric coefficient of
the metabolite in the respective reaction.
When using KEGG COMPOUND and KEGG REACTION data
for a network reconstruction, some obstacles have to be addressed.
One of them is reaction directionality. For the reactions contained in
KEGG, the reaction directions are not indicated in the database entries.
There is thus a need for further reaction data to annotate directionality.
To do so, we use the component contribution method of the
biochemical thermodynamics calculator eQuilibrator (Flamholz, Noor,
Bar‐Even, & Milo, 2012; Noor, Haraldsdóttir, Milo, & Fleming, 2013) to
compute the ΔrG′m value (the change of the Gibbs free energy of a
reaction at a given pH of 7 and ionic strength I in 1mM concentration of
the reactants) for each reaction in the network and infer if the
respective reaction is reversible. Reactions with ∣ΔrG∣ ≤15 kJ/mol are
designated as reversible. In biological systems as well as in most
biosynthetic setups, concentrations of substrates and products often
differ by several orders of magnitude. This significantly influences
reaction reversibility. As these effects cannot be adequately considered
given the size of the networks presented in this study and the unknown
kinetics, the ΔrG value of 15 kJ/mol was chosen as a consensus value to
determine reaction reversibility. This somewhat arbitrary value
represents a compromise between the assumption of reversibility of
all reactions and a more stringent restriction with a ΔrG value of less
than 15 kJ/mol that would potentially exclude feasible biosynthetic
routes with concentrations of intermediates adjusting in a running
system. The value was set after a series of simulations and expert
inspection of results. However, the user of our tool can freely set the
ΔrG cutoff to meet the needs of his specific investigation. The reactions
are added to the model in the respective direction(s), which means that
for each reversible reaction, we get two reactions in the respective
directions. Another obstacle is the inconsistent use of identifiers for
metabolites. In some reaction equations, the KEGG COMPOUND (C)
identifiers are used, and in others, the G identifiers from the
KEGG GLYCAN structure database. As we do not consider glycans,
those reactions are excluded. For polymerization reactions, the reaction
stoichiometry in KEGG is not expressed in distinct numbers. Such
reactions are not applicable for our method where the coefficients in
the stoichiometric matrix are required to be integer numbers.
We did not generally exclude membrane‐associated reactions. To
our knowledge, it is not sufficiently clear whether and to what extent
intracellular as well as extracellular membrane‐associated enzymes are
active in permeabilized cells. In earlier work, we could, however,
experimentally show that megasynthases producing a circular
oligopeptide can be kept active in permeabilized cells in contrast to
cell extracts where activities could not be detected (Weyler & Heinzle,
2017). The exact reasons were not identified but could potentially be
related to yet unknown membrane association. On the other hand, in
selectively permeabilized eukaryotes, the organelles including
membrane reactions remain intact and functional (e.g., Nicolae,
Wahrheit, Nonnenmacher, Weyler, & Heinzle, 2015).
We thus have to filter the KEGG data before building a model.
Figure 3 shows the filtering steps to obtain the reactions suitable for
building a reconstruction of a pan‐organism network encompassing
reactions from all organisms and also for organism‐specific networks.
The filtering starts with all 11,196 reactions in KEGG REACTION.
First, the reactions with invalid reactants are removed, which are
reactants that do not have a C identifier. The 10,764 remaining reactions
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are further trimmed down to 10,603 reactions with valid stoichiometry,
where all reactants have integer stoichiometric coefficients. From these,
reactions that are generic or contain generic reactants (i.e., the database
entry has a comment containing ‘generic,’ ‘incomplete,’ or ‘general’) are
removed, sparing 7,989 reactions. After removing those without any
reaction class annotations, 7,676 reactions remain in the pan‐organism
model, which corresponds to about 69% of all KEGG reactions.
To build the organism‐specific models, the organism annotation
for the genes of the enzymes catalyzing those reactions is
used. From the 7,676 reactions in the pan‐organism network
reconstruction, KEGG has Enzyme Commission numbers associated
with 5,975 reactions. Out of those, 4,549 (76%) have enzymes whose
genes are annotated with organisms. These reactions are the basis of
the organism‐specific network model reconstructions.
Our network reconstruction workflow filters out ill‐formed
reaction entries in KEGG. However, we do not include a gap filling
step. This would require large manual efforts that are not in the
scope of this study.
Possible target metabolites in KEGG for the computation of
synthesis pathway candidates are determined automatically. A target
metabolite is a metabolite in the respective model that is not a
dedicated start or basis metabolite. It also has to appear as a product in
at least one arc in the network, so it could be potentially produced. We
predict potentially producible targets in a given model by determining
its feasible reactions, that is, reactions for which potentially all
substrates are available or producible. The feasible reactions are
obtained by initially starting with the set of metabolites consisting of
the model’s start metabolites and cofactors/inorganics. With these
metabolites, all reactions that are feasible are determined by checking
for each reaction that has not already been added to the set of feasible
reactions if all substrates are available. The products of these feasible
reactions are added to the set of metabolites. This step is repeated until
no new substrates are added. The resulting set of reactions is then a
subset of the model’s reactions that potentially are feasible.
The next step is to do a reachability screening in the arc graph of the
model. To do so, we add a node representing an artificial start metabolite
that is connected to all potential start metabolites. From there, we do a
breadth‐first search in the graph. Breadth‐first search is a suitable
algorithm for exploring a graph. The search starts with a source vertex
and discovers all neighboring vertices with the present depth before
discovering the next depth‐level vertices (Cormen, Leiserson, Rivest, &
Stein, 2009). The potentially producible targets are those targets that
are connected with the start node by a path (a sequence of edges that
connect vertices) and that are produced by any of the feasible reactions.
2.3 | Computational details
The model data are based on KEGG release 90.1, May 1, 2019. The code
for model building and statistics is written in Python 2.7, the code for the
thermodynamics is written in Python 3.6 using the eQuilibrator API
(Flamholz et al., 2012). We furthermore used the packages—graph‐tool
(Peixoto, 2014) and Matplotlib (Hunter, 2007). The path‐finding tool was
run on MATLAB R2019a with IBM CPLEX Studio 12.9. All computations
were carried out on a 2.5Ghz Intel Core i7 with 32GB of RAM.
The software used in this study is available at https://github.com/
mecatsb, where the repository mecat contains the path‐finding tool
and the repository mecatpy contains the code used for the pathway
analysis as well as the organism models. Release v1.0 contains the
code version used in this study.
3 | RESULTS
We first present the organisms and models used in our study and
then discuss some interesting properties of these models. We finally





 not general or generic reaction
7989
reactions with RCLASS entries
7676











F IGURE 3 Reaction filtering from all reactions in Kyoto
Encyclopedia of Genes and Genomes (KEGG) to the set of reactions
for building the pan‐organism network reconstruction and the
organism‐specific models. The reactions are filtered in the given
order. The numbers indicate how many reactions stay after filtering.
The width of the box bases are proportional to the number of
reaction that remain after filtering
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3.1 | Models
For each organism in the KEGG Organisms database, we build an
organism‐specific network model, as described in Section 2.2. Figure 4
shows the number of reactions in KEGG that are annotated for the
specific organism together with the number of reactions that are part
of the organism‐specific network reconstruction. The organisms are
sorted in descending order with respect to the number of annotated
reactions in the model. The order in which the reactions are filtered
is following the procedure shown in Figure 3.
On average, 67% of the reactions in KEGG that are annotated
with an organism end up in an organism‐specific model (see insert in
Figure 4). The reason for this is the filtering of all reactions according
to the filter constraints shown in Figure 3 and discussed in detail in
Section 2.2. Figure 3 shows that the majority of the discarded
reactions are general and/or generic or contain generic reactants.
In addition to the pan‐organism network model, we chose nine
organism‐specific models for all network and pathway analyses as
examples. Table 1 lists the organisms, which were chosen primarily for
their importance in biotechnological production as well as in scientific
research. CHO, the permanent cells of the ovary of a Chinese hamster C.
griseus were originally isolated already in 1957. CHO is serving as a
model cell line for metabolic studies. Most importantly, however, it is
most frequently used for the industrial heterologous production of
therapeutic proteins (Lalonde & Durocher, 2017; Wurm, 2004). The
application of animal cells for biosynthetic purposes is easier starting
from cell lines like CHO rather than cells from primary tissues.
Escherichia coli is probably the most important model organism and is
used in all kinds of areas spanning from basic molecular biological work
to industrial applications (Pontrelli et al., 2018). Vibrio natriegens is an
extremely fast growing marine bacterium that recently got increasing
interest. Due to its duplication time of 10 minutes, it has been in the
focus of molecular biology research, for example, for protein production
also in cell‐free systems (Failmezger, Scholz, Blombach, &
Siemann‐Herzberg, 2018; Hoffart et al., 2017). Pseudomonas putida is
known for its diverse biodegration and biosynthetic capabilities
(Loeschcke & Thies, 2015; Nikel, Chavarria, Danchin, & de Lorenzo,
2016; Poblete‐Castro, Becker, Dohnt, DosSantos, & Wittmann, 2012).
Myxococcus xanthus is a model organism for studying social behavior of
bacteria with extended signaling networks and secondary metabolite
production (Wrótniak‐Drzewiecka, Brzezińska, Dahm, Ingle, & Rai,
2016). Saccharomyces cerevisiae is probably the most important
eukaryotic model micro‐organism used very widely and already for a
long time for the production of ethanol in alcoholic beverages and
biofuel. It is also widely discussed for the production of other
metabolites and its broad application is supported by a large toolbox
for metabolic engineering (Krivoruchko & Nielsen, 2015; Nielsen, 2019;
Steensels et al., 2014). The yeast Schizosaccharomyces pombe is a model
organism primarily used in molecular and cell biology but is recently
also discussed as promising candidate for the expression and secretion
of heterologous proteins (Takegawa et al., 2009). Corynebacterium
glutamicum is a most important micro‐organism in the industrial scale
production of amino acids but also other metabolic products (Becker,
Gießelmann, Hoffmann, &Wittmann, 2016). While these organisms have
been used in a vast range of production processes, they are also well
understood and we assume that KEGG data on these organisms is
relatively complete and accurate. Mycoplasma penetrans has the
smallest genome of known organisms and its metabolism is very limited
(Sasaki et al., 2002). From the present view, the most important
organisms for cell‐free synthesis are E. coli, S. cerevisiae, P. putida, and
M. xanthus. We exclude plants and algae from our species models since
they seem less applicable from the present view on cell‐free biocatalysis.
All model data are part of the GitHub repository https://github.
com/mecatsb/mecatpy.
Table 2 shows the number of potential targets for the respective
model as defined in Section 2.2. The arc reachable targets are those
targets that are connected to a basis metabolite via an arc path,
which is determined by breadth‐first search. The feasible targets are
targets that are products of feasible reactions as described in Section
2.2. The set of potentially producible targets is the intersection of the
targets that are connected to a basis metabolite via an arc path and
the targets that are products of the feasible reactions.
Table 2 shows that a large portion of potential targets is not
connected to any of the basis metabolites in the model. For all
models, about 32% (in the S. pombe model spo) to 43% (in the
pan‐organism model kegg) of all potential targets are potentially
producible targets. This means that for all other potential targets, a
synthesis pathway cannot be found, as a path is a required part of a
valid solution. We will elaborate the reasons for this drastic
reduction later in this study.
3.2 | Network model analysis
We first present some basic properties of the arc graphs of the
different organism models.
F IGURE 4 Comparison of the total number of reactions and the
number of reactions selected for the models for all organisms
annotated in KEGG. KEGG, Kyoto Encyclopedia of Genes and
Genomes [Color figure can be viewed at wileyonlinelibrary.com]
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Figure B1 in Material S2 shows the node degree distributions of
the arc graphs of the different organism network reconstructions.
The degree of a node is the number of edges leaving it (out‐degree)
plus the number of edges entering it (in‐degree). Tables B1–B10 in
Material S2 list the hubs with the top five occurrences of each
network. As expected, pyruvate, L‐glutamate, D‐glyceradehyde
3‐phosphate, and acetyl‐CoA are in almost all cases metabolites
with highest node degrees. M. penetrans (mpe), having the smallest
network of all studied here, differs most significantly from all
others both in the types of metabolites with highest node degrees
as well as in the generally small numbers of node degrees (<13). In
the pan‐organism network model (kegg), trans,trans‐farnesyl
diphosphate has an exceptionally high node degree (107), that is,
however, mostly originating from plant metabolism. In kegg,
pyruvate is by far the most connected metabolite with a node
degree of 167. The outstanding role of only a few metabolites is
most strikingly seen in Figure B1 of Material S2.
The sizes of the arc graphs together with the average node
degrees, standard deviation of the distribution are listed in Table B11
of Material S2. It is interesting to see that the average node degrees
vary only from 2.37 to 3.14 for individual organisms and 3.3 for kegg,
the pan‐organism network.
Table 3 lists the number of connected components of the
arc graphs in the respective models and the size of the
largest connected component, respectively. A connected compo-
nent in the graph is a subgraph where each vertex in the subgraph
is connected to each other vertex in the subgraph by a path
(Cormen et al., 2009).






kegg Pan‐organism network model 11,196/7,676/2,934 5,467 6,473/39
cge Cricetulus griseus (Chinese hamster) 2,616/1,555/639 922 1,485/39
eco Escherichia coli K‐12 MG1655 1,775/1,225/511 950 1,191/39
vna Vibrio natriegens 1,690/1,193/489 888 1,180/39
ppun Pseudomonas putida NBRC 14164 1,683/1,199/469 766 1,240/37
mxa Myxococcus xanthus 1,492/1,021/428 684 1,077/36
sce Saccharomyces cerevisiae (budding yeast) 1,543/1,020/403 655 1,031/39
spo Schizosaccharomyces pombe (fission yeast) 1,408/905/378 592 915/39
cgb Corynebacterium glutamicum ATCC 13032 (Bielefeld) 1,122/792/318 534 845/38
mpe Mycoplasma penetrans 371/236/101 166 314/22
Note: The model names are derived from the KEGG organism codes, except for the pan‐organism network model, which is named kegg. The number of
reactions in KEGG refers to the number of reactions that are annotated for the respective organism. The number of reversible reactions is the
corresponding subset of the reactions in the model. The feasible reactions are determined as described in Section 2.2 based on the set of basis
metabolites as start metabolites. The basis metabolites are selected as described in Section 2.2.
Abbreviation: KEGG, Kyoto Encyclopedia of Genes and Genomes.












kegg 5,441 3,017 2,412 2,325 43
cge 1,128 437 358 333 30
eco 878 419 376 351 40
vna 865 397 348 328 38
ppun 902 380 317 293 32
mxa 777 320 281 266 34
sce 713 268 243 227 32
spo 637 264 216 201 32
cgb 598 261 215 200 33
mpe 184 70 69 56 30
Note: Arc reachable targets: targets that are connected to a basis metabolite via an arc path; feasible targets: targets that are products of feasible
reactions as described in Section 2.2; potentially producible targets: targets that are connected to a basis metabolite via an arc path and that are products
of feasible reactions and are thus realistic targets, intersection of the former two columns of the table; % of potential targets: percentage of potentially
producible targets in relation to the total number of potential targets.
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The smallest connected components contain two vertices in all
models. This is by definition the smallest component size as the
arc graph does not contain metabolites without any arcs. We
furthermore list the number of components containing basis
metabolites; as well as the total number of metabolites in all those
components with the percentage of those metabolites in relation to
the number of metabolites in the arc graph (in parentheses). These
numbers give information on how much of each network is possibly
reachable from the designated start points, since a potentially
producible target has to be connected to any of the predefined basis
metabolites via an arc path. Table 3 shows that between half and
two‐third of the metabolites in a model’s arc graph are contained in a
component with basis metabolites.
Exemplarily, Figure 5 shows the arc graph of the pan‐organism
model kegg. The arc graph consists of a large main component and a
large number of small components. Components in red are
components containing potential start metabolites, whereas the
components in blue are the so‐called satellite components without
start metabolites. The arc graphs of the other models are shown in
Figure B2 of Material S2. Figure B3 of Material S2 shows the arc
graph component histograms.
There are several reasons for isolated components in a model. The
first reason is missing annotation in the data on which the model is
based. This could be improved by using manually compiled and curated
network reconstructions with gap filling. Several reactions in KEGG are
formulated as general reactions and/or are reactions containing generic
compounds. Some of the often numerous reactions summarized in such
reactions are explicitly listed in KEGG. An even larger number could, in
principle, be added, for example, from BRENDA (Jeske, Placzek,
Schomburg, Chang, & Schomburg, 2018). Some reactions involve
additional proteins that transfer electrons or groups or use covalently
bound cofactors as, for example, nicotinamide adenine dinucleotide
phosphate. These are filtered out in the model building process. As we
do not include such reactions in our model, some metabolic pathways
could be cut off. Another reason is that a component is really isolated.
In Material S3, we list all components identified in the kegg
model. The 6,246 metabolites are grouped in 481 components.
The largest component connected to start metabolites comprises
4,612 metabolites and is represented in the center of Figure 5. All
other components with a size of 5 or more metabolites were
investigated in more detail (Material S4). They comprise 682
metabolites in 69 components. We could identify some typical
families related to biochemical characteristics (Material 5). Reactions
of xenobiotic compounds, for example, drugs, were most prominent
with 14 components with 141 metabolites followed by polyketides
(10/109), carbohydrate‐derived metabolites (10/86), terpenoids
(9/112), compounds with gonane tape nucleus (7/74), fatty acid
and lipids related compounds (7/59), and flavonoids (4/54).
Xenobiotics are inherently not listed in the starting metabolites.
Some of these families have often general reactions or involve
generic metabolites, for example, metabolites contain a group ‐R that
is not explicitly specified. R is later cleaved off the metabolite.
Smaller components (<5) were not analyzed in detail but could
often serve as missing links in larger pathways once the
connecting reactions could be defined following the criteria specified
in Section 2.2.
3.3 | Reachability analysis
We determined the target reachability in the organism‐specific
networks by testing the existence of a pathway candidate to each
TABLE 3 Number of components in the models with the number















kegg 481 4,612 1 4,612 (74%)
cge 186 754 4 763 (55%)
eco 139 766 2 768 (69%)
vna 146 726 1 726 (66%)
ppun 157 761 2 763 (66%)
mxa 159 587 3 595 (60%)
sce 182 478 1 478 (50%)
spo 162 438 1 438 (52%)
cgb 115 457 2 459 (60%)
mpe 57 76 7 141 (54%)
Note: The fourth column lists the number of components containing basis
metabolites. The last column shows the number of metabolites that
belong to a component containing basis metabolites. The percentage of
those metabolites in relation to the number of metabolites in the arc
graph is shown in parentheses.
F IGURE 5 Arc graph of the pan‐organism model kegg. Red:
components containing potential start metabolite; blue: satellite
components without start metabolites [Color figure can be viewed at
wileyonlinelibrary.com]
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possible target starting with basis metabolites using our MILP
presented in Section 2.1. Figure 6 shows for each model the
percentage of targets for which a synthesis pathway candidate has
been identified and for which a pathway candidate is not accessible
and why. The raw data for the figure is listed in Table B17 of Material
S2. In the following, we discuss the different fractions in more detail.
The blue and orange fractions represent the targets for which a
synthesis pathway candidate has been identified in the respective
models. The targets represented by the orange fractions have been
predicted to have a pathway candidate. This means that they can be
produced by feasible reactions of the model and they are connected to
at least one of the predefined basis metabolites by a path in the arc
graph (see Section 2.2). An example for this category is UDP‐glucose
(Material S6, Section F.1). However, the targets represented by the
blue fractions have not been predicted to be feasible, despite having a
synthesis pathway candidate. For those targets, we found that most of
the pathway candidates calculated with the MILP include a direct cycle
formed by supplying reactions that use metabolites that are not in the
metabolite pool. In a mathematical sense, it is valid to consume a
metabolite as long as its overall balance is zero. However, in real world
applications, this would not be correct since the metabolite has to be
present in at least catalytic amounts already at the start of the
reaction. An example for such a pathway is the pathway candidate for
the 5‐methyl‐5,6,7,8‐tetrahydromethanopterin (C04488) production
in the pan‐organism network model kegg (Material S6, Section F.2).
The pathway requires coenzyme F420 (C00876) and reduced
coenzyme F420 (C01080), which are neither metabolites nor
cofactors, and thus are not part of the metabolite pool. They thus
have to be produced by the reactions of the pathway.
The green, red, purple, and brown fractions represent targets
without any pathway candidate. In the following, we will discuss the
different reasons for this.
With the help of breadth‐first search, we found that the targets
represented by the green and red fractions are not connected to any
of the potential start metabolites via an arc path. Therefore, these
targets cannot have a pathway candidate, since a path from a start
metabolite to the target is mandatory, as stated in Section 2.1.
The targets belonging to the green category are not part of a
component containing potential start metabolites. In our pan‐organism
model kegg, this is the case for proansamycin X. Component 134 in
Material S4 shows that there is no reaction in KEGG producing
proansamycin X (C12176) from 3‐amino‐5‐hydroxybenzoate (C12107),
which belongs to a component with start metabolites (Material S3). The
situation could be improved by using manually compiled and curated
network reconstructions with gap filling, for example, for metabolites of
the earlier discussed polyketide, flavone, and terpenoid families (see
also Material S5). As outlined in Section 2.2, we only did some minor
generic curation which has the purpose of extracting meaningful data
and removing ill‐specified data. A comprehensive network reconstruc-
tion for an organism would require a lot of manual work encompassing
more data sources including primary literature, which was not in the
scope of this study. However, when using our path‐finding method, the
user can choose any network model that contains the information
needed for path‐finding, regardless of data origin.
The targets represented by the red fractions are contained in
components with start metabolites but do not have a necessary arc path
from a start metabolite to the target, such as riboflavin (C00255).
The targets represented by the purple fractions are connected to a
potential start metabolite in the network via an arc path. However, this
is not sufficient for a valid pathway candidate. In addition, the arcs have
to be associated with reactions for which all substrates are available or
producible to ensure that the pathway candidate is feasible (Blaß et al.,
2017). However, for these targets, there is no reaction in the set of
feasible reactions (see Section 2.2) that produces that target for the last
one arc of the arc path, which means that the overall pathway is not
feasible. Note that the other arc‐reaction associations thus do not
matter in this case. An example for such a target is biotin (C00120;
Material S6, Section F.3).
The targets represented by the brown fractions are targets that are
predicted to have pathway candidates as they are connected to
predefined start metabolites by an arc path and are produced by
feasible reactions. However, our path‐finding algorithm could not
determine valid pathway candidates. To explore the reasons for this,
we list the feasible reactions of the respective models that produce these
F IGURE 6 Analysis of the target search in the different organism
models. blue: targets for which a pathway candidate has been found by
our method, but that have not been predicted as feasible; orange:
targets for which a pathway candidate has been found by our method;
green: targets for which a candidate has not been found due to the
absence of an arc path from any start metabolite to the target because
the target is in a satellite component without start metabolite; red:
targets for which a candidate has not been found due to the absence of
an arc path from any start metabolite to the target (and the target is in
a component with start metabolites); purple: targets for which a
candidate has not been found due to the lack of a feasible reaction that
produces the target; brown: targets for which a candidate has not been
found due to other reasons that are discussed in the text [Color figure
can be viewed at wileyonlinelibrary.com]
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targets for each of those targets. For each of these reactions, we
determine why it is not part of a pathway candidate. We identified three
non‐disjoint categories in which we can sort these reactions. To the first
category, belong reactions that produce the target but do not have arcs
containing the target. As discussed in Section 2.1, a valid pathway
candidate has to include a reaction with an arc to the target. Reactions
that produce the targets only from substrates that are designated
cofactors or inorganic metabolites are also sorted to this category, as
they are correctly predicted to be feasible. However, our path‐finding
method does not handle such pathways since a valid pathway candidate
requires at least one arc by definition and there are no arcs containing
cofactors and inorganic metabolites. The second category encompasses
reactions that do have an arc to the target, but require a substrate that is
also a target for which no pathway candidate has been identified with
our method. The reactions in the third category cannot be used in a
pathway candidate because of a constraint in the MILP, which excludes
pathways that use reactions consuming the target, as discussed in
Section 2.1. There is no valid sequence of reactions with arcs that is
feasible without using supplying reactions that consume the target. An
example for a target of the brown fraction is 5′‐methylthioadenosine
(C00170), where the reactions producing this target belong to the first
two categories discussed above (Material S6, Section F.4).
To illustrate the different target categories, the example arc graph
in Figure 7a depicts examples for each of the categories. Note that, for
the sake of clarity, the depicted arc graph has additional vertices for the
cofactors (small circles), which would normally not be part of the graph.
The potential start metabolites A and B are depicted by hexagons, the
potential targets E, F, G, and H by octagons. Figure 7b lists the reaction
equations and the arcs belonging to these reactions. A valid pathway
candidate to E consists of the reactions R1 and R3 (arcs 1, 2, and 4),
since all needed substrates, that is, A, B, and Y, are available. E would
thus be a target represented by the orange fractions in Figure 6.
For target F, it is not possible to find a pathway candidate because
F is part of a graph component that does not include potential start
metabolites. F is thus an example of the green fractions. Target G is
part of the component which also includes the potential start
metabolites. However, there is no arc path connecting metabolites A
or B to G, which makes G a target represented by the red fractions.
Target H is an example for the purple fraction. To reach H, there are
valid arc paths (e.g. 1→ 5→ 8 or 2→ 5→ 8), however, the last reaction
belonging to arc 8 requires W as a substrate, which is not available.
4 | CONCLUDING REMARKS
Our presented method allows creating and characterizing genome‐scale
metabolic network reconstructions for the planning of biosynthetic
production pathways using cell‐free systems. The data are taken from
biological databases, for example, KEGG. We also discussed typical
problems in the context of network reconstruction and how these can be
solved to obtain applicable network models. We used the presented
method for establishing models for the network reconstruction of a
pan‐organism from the whole KEGG database as well as for several
interesting model organisms. We also used our path‐finding method
based on a global optimization problem to compute pathway candidates
for all possible target molecules in the models and demonstrated that our
method yields correct and meaningful results and that it is widely
applicable for all kinds of networks and network sizes. The increasing
availability of larger‐scale metabolic networks that are increasingly well
curated, as is for example, already the case for E. coli and S. cerevisiae
(Orth et al., 2011; Zomorrodi & Maranas, 2010), will also increase the
power of our method. Our network analysis method for multienzyme
systems that do not have any cellular compartments particularly
lacking a cell membrane differs significantly from published methods
for whole cells with a defined link to the extracellular environment via
(a)
(b)
F IGURE 7 Arc graph with examples for the different target
categories in Figure 6 and the corresponding reactions. (a) Small circles:
cofactor metabolites; hexagons: potential start metabolites; octagons:
potential targets; large circles: metabolites not in any of the previous
categories. Orange: target of the orange category; green: target of the
green category; red: target of the red category; purple: target of the
purple category. The numbers on the arcs refer to the column ‘arcs’ in
(b). (b) Reactions in the example network with their respective reaction
equations [Color figure can be viewed at wileyonlinelibrary.com]
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transport systems (S. Z. Wang et al., 2017; von Kamp, Thiele, Hädicke, &
Klamt, 2017) or with models of microbial communities, for example,
Magnúsdóttir and Thiele (2018).
The tools we presented are directly applicable to designing the
synthesis of target compounds in cell‐free systems. Our analysis tools
—especially the feasibility prediction we described in Section 2.2—are
useful tools to predict if a target could potentially be produced
in a given model and could thus be used to quickly screen if a
host organism or strain is potentially capable of producing a certain
product directly.
If this is not the case, a comparison of biosynthesis pathways in a
selected host organism and in the pan‐organism is useful for
identifying genetic engineering targets to create a production
organism eventually. Our tools help to identify heterologous enzymes
that might be candidates for insertion in the host organism chosen
using genetic engineering to complete a desired pathway in that
organism. Our tools also help to answer which substrates are
required for a certain synthesis pathway.
Biosynthesis pathway candidates including stoichiometric and
thermodynamic constraints can be determined with our presented
path‐finding algorithm presented earlier (Blaß et al., 2017).
As reviewed in a recent publication (Lin, Warden‐Rothman, &
Voigt, 2019), various methods have already been published and are
in development that additionally allow the identification of new
reactions considering the promiscuity of many enzymes but also the
chemical similarity of substrates of these enzymes.
Our network reconstructions are the basis for the identification of
gaps in the network that would prohibit synthesis of a desired target.
With our tools, it is possible to identify potential gap fillers from the
pan‐organism network, which can then be implemented in an organism
of interest using genetic engineering. It is also possible to do manual
directed gap filling in the pan‐organism network, for example, by
considering generic reactions, reactions not contained in KEGG, or
expert reasoning.
Overall, our tools and networks are a suitable basis for focused
and directed experimental work and the implementation of the
synthesis of target compounds in cell‐free systems.
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